| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/IJC.31115 |
| P698 | PubMed publication ID | 29047105 |
| P50 | author | Zhi-Jun Sun | Q87814766 |
| P2093 | author name string | Lei Wu | |
| Bing Liu | |||
| Lu Zhang | |||
| Ashok B Kulkarni | |||
| Jian-Feng Liu | |||
| Liang Mao | |||
| Wen-Feng Zhang | |||
| Zhi-Li Zhao | |||
| Wei-Wei Deng | |||
| Guang-Tao Yu | |||
| Lin-Lin Bu | |||
| Yi-Cun Li | |||
| P2860 | cites work | Hallmarks of Cancer: The Next Generation | Q22252312 |
| Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards | Q26744395 | ||
| Notch signaling: an emerging therapeutic target for cancer treatment | Q26784068 | ||
| The blockade of immune checkpoints in cancer immunotherapy | Q27860852 | ||
| Notch signaling: cell fate control and signal integration in development | Q27861061 | ||
| Immune checkpoint blockade: a common denominator approach to cancer therapy | Q28083981 | ||
| Comprehensive genomic characterization of head and neck squamous cell carcinomas | Q28256121 | ||
| Coordinated regulation of myeloid cells by tumours | Q28395157 | ||
| Tumor-specific T-cell help is associated with improved survival in melanoma. | Q47988747 | ||
| Development of immuno-oncology drugs - from CTLA4 to PD1 to the next generations. | Q50885033 | ||
| Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1 | Q29614651 | ||
| The mutational landscape of head and neck squamous cell carcinoma | Q29614654 | ||
| Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma | Q29615443 | ||
| Notch signaling | Q29618190 | ||
| Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors | Q33707098 | ||
| Specific fibroblastic niches in secondary lymphoid organs orchestrate distinct Notch-regulated immune responses | Q34375200 | ||
| The cellular and molecular origin of tumor-associated macrophages | Q34378833 | ||
| Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens | Q34788858 | ||
| Notch1 mutations are drivers of oral tumorigenesis | Q35251675 | ||
| Loss of TGF-β signaling and PTEN promotes head and neck squamous cell carcinoma through cellular senescence evasion and cancer-related inflammation. | Q35722714 | ||
| Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update | Q35904534 | ||
| Cytoreduction surgery reduces systemic myeloid suppressor cell populations and restores intratumoral immunotherapy effectiveness | Q36161355 | ||
| Chemopreventive and chemotherapeutic actions of mTOR inhibitor in genetically defined head and neck squamous cell carcinoma mouse model. | Q36295853 | ||
| ROR1C Regulates Differentiation of Myeloid-Derived Suppressor Cells | Q36345203 | ||
| CD45 Phosphatase Inhibits STAT3 Transcription Factor Activity in Myeloid Cells and Promotes Tumor-Associated Macrophage Differentiation | Q36595788 | ||
| NOTCH1 inhibition enhances the efficacy of conventional chemotherapeutic agents by targeting head neck cancer stem cell. | Q36830276 | ||
| The tumor microenvironment is a dominant force in multidrug resistance. | Q36856829 | ||
| MicroRNA-135b acts as a tumor promoter by targeting the hypoxia-inducible factor pathway in genetically defined mouse model of head and neck squamous cell carcinoma | Q36863089 | ||
| Myeloid-Derived Suppressor Cells Endow Stem-like Qualities to Breast Cancer Cells through IL6/STAT3 and NO/NOTCH Cross-talk Signaling. | Q36963408 | ||
| Targeting STAT3 signaling reduces immunosuppressive myeloid cells in head and neck squamous cell carcinoma | Q37012605 | ||
| CTLA4 blockade reduces immature myeloid cells in head and neck squamous cell carcinoma | Q37079094 | ||
| Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers | Q37381036 | ||
| Effects of notch signaling on regulation of myeloid cell differentiation in cancer | Q37456808 | ||
| Common and complex Notch1 mutations in Chinese oral squamous cell carcinoma | Q37624624 | ||
| Hematopoietic cytokine-induced transcriptional regulation and Notch signaling as modulators of MDSC expansion | Q37856017 | ||
| Tumor-associated macrophages: from mechanisms to therapy | Q38230880 | ||
| Cooperative regulation of NOTCH1 protein-phosphatidylinositol 3-kinase (PI3K) signaling by NOD1, NOD2, and TLR2 receptors renders enhanced refractoriness to transforming growth factor-beta (TGF-beta)- or cytotoxic T-lymphocyte antigen 4 (CTLA-4)-med | Q38420016 | ||
| The Notch pathway in colorectal cancer | Q38564689 | ||
| Forced Activation of Notch in Macrophages Represses Tumor Growth by Upregulating miR-125a and Disabling Tumor-Associated Macrophages | Q38804285 | ||
| Myeloid-derived suppressor cells as effectors of immune suppression in cancer. | Q38864758 | ||
| Endothelial cell-secreted EGF induces epithelial to mesenchymal transition and endows head and neck cancer cells with stem-like phenotype | Q39009747 | ||
| Mouse and human Notch-1 regulate mucosal immune responses. | Q39034381 | ||
| Autocrine and paracrine loops between cancer cells and macrophages promote lymph node metastasis via CCR4/CCL22 in head and neck squamous cell carcinoma. | Q39238857 | ||
| B7-H4 expression indicates poor prognosis of oral squamous cell carcinoma | Q39627356 | ||
| Notch signaling determines the M1 versus M2 polarization of macrophages in antitumor immune responses | Q39700430 | ||
| Association of Notch pathway down-regulation with Triple Negative/Basal-like breast carcinomas and high tumor-infiltrating FOXP3+ Tregs. | Q42492427 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | head and neck squamous cell carcinoma | Q18348812 |
| P1104 | number of pages | 11 | |
| P304 | page(s) | 999-1009 | |
| P577 | publication date | 2017-11-02 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | γ-Secretase inhibitor reduces immunosuppressive cells and enhances tumour immunity in head and neck squamous cell carcinoma | |
| P478 | volume | 142 |
| Q92060208 | A novel triazole, NMK-T-057, induces autophagic cell death in breast cancer cells by inhibiting γ-secretase-mediated activation of Notch signaling |
| Q90398004 | FLI-06 Intercepts Notch Signaling And Suppresses The Proliferation And Self-renewal Of Tongue Cancer Cells |
| Q57283037 | Inhibiting Notch1 enhances immunotherapy efficacy in melanoma by preventing Notch1 dependent immune suppressive properties |
| Q92731408 | Modulation of Immunosuppression by Oligonucleotide-Based Molecules and Small Molecules Targeting Myeloid-Derived Suppressor Cells |
| Q59791901 | Moving Breast Cancer Therapy up a Notch |
| Q55210384 | Notch Signaling in Macrophages in the Context of Cancer Immunity. |
| Q58572862 | Notch and NF-κB: Coach and Players of Regulatory T-Cell Response in Cancer |
| Q89771836 | Overview of Basic Mechanisms of Notch Signaling in Development and Disease |
| Q92366436 | Precision medicine for human cancers with Notch signaling dysregulation (Review) |
| Q89587286 | Shaping of the Tumor Microenvironment by Notch Signaling |
| Q92642526 | Targeting Cellular Metabolism Modulates Head and Neck Oncogenesis |
| Q52571053 | Targeting Notch signalling pathway of cancer stem cells. |
Search more.